子宮內(nèi)膜異位癥(endometriosis)張喜_第1頁(yè)
子宮內(nèi)膜異位癥(endometriosis)張喜_第2頁(yè)
子宮內(nèi)膜異位癥(endometriosis)張喜_第3頁(yè)
子宮內(nèi)膜異位癥(endometriosis)張喜_第4頁(yè)
子宮內(nèi)膜異位癥(endometriosis)張喜_第5頁(yè)
已閱讀5頁(yè),還剩38頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

1、 definition common sites of endometriosis the most common sites: uterosacral ligament rectouterine pouch ovary others: uterine serosa fallopian tube sigmoid colon (乙狀結(jié)腸) outside of the pelvis : umbilicus(臍) , bladder, kidney prevalence present in 10%-15% of women in reproductive age group, especiall

2、y from age 25 to 45 normally not seen before age 15 or after menopause early and more childbearing latest study: more frequent menses (cycle length 27 days ) and prolonged menstrual flow ( 1 week) 2 times risk theories of sources of ectopic endometrium endometrial implanting theory ( (種植學(xué)說種植學(xué)說) ) sa

3、mpson 1921 endometrium transfer implant grow retrograde menstruation (經(jīng)血逆流) theory transport by lymph and vein iatrogenic ( (醫(yī)源性的醫(yī)源性的) ) implantation theories of source of ectopic endometrium metaplasia theory(化生學(xué)說) inducement theory(誘導(dǎo)學(xué)說) factors related with endometriosis genetic abnormalities :hi

4、gh risk in first-degree relatives immunologic factors : increased concentrations of white blood cells, cytokines, and growth factors il-6、il-8、tnf-、mcp-1 inflammation: ems lesions chronic pelvic inflammation pathology ectopic endometrium hemorrhage proliferation of fibrous tissue adhesions dark blue

5、 or dark brown spots scarring nodules or cysts gross appearance : ovarian endometriosis red, blue, or brown spots endometriomas chocolate cysts gross appearance : peritoneal endometriosis common sites: uterosacral ligament、rectouterine pouch upurple spots udark brown spots ured lesions uwhite lesion

6、s uperitoneum lack peritoneal endometriosis peritoneal endometriosis cervix umbilicus(臍) : endometrial glands endometrial stroma fibrin red blood cells and hemosiderin(含鐵血黃素) 2 findings to be diagnosed symptoms: dysmenorrhoea(痛經(jīng))(痛經(jīng)) and chronic pelvic pain the most typical symptom:secondary dysmeno

7、rrhea that worsens over time dyspareunia(性交痛)(性交痛) abnormal uterine bleeding heavy menses, prolonged menstruation or premenstrual spotting infertility:40% of patients acute abdomen: inter-cyst hemorrhage(囊內(nèi)出血), or rupture symptoms: others: diarrhoea(腹瀉) constipation(便秘) bloody stool painful urinatio

8、n bloody urine backache causes of infertility 1) mechanical reason 2) environmental change in the peritoneal cavity 3) abnormal immune function 4) abnormal ovarian function (anovulation,lpd, lufs) 5) increase in spontaneous abortion pelvic examination: fixed retroverted uterine tender nodules on ute

9、rosacral ligament or rectouterine pouch tender and fixed adnexal masses diagnosis history pelvic examination laparoscopy golden diagnosis standard diagnosis, classification treatment ultrasound, (ct and mri, expensive) serum ca125 but usually 100iu/ml anti-endometrium antibody diagnosis clinical cla

10、ssification revised american fertility society (r-afs), 1985 useful for: assessment of severity selection of therapeutic regimen comparison prognosis r-afs differential diagnosis ovarian tumor ascites(腹水)(腹水), solid or mixed, b ultrasound image, ca-125100 iu/ml abdominal inflammatory mass history of

11、 infection, fever, not cyclic, treatment with antibiotics effectively adenomyosis (子宮腺肌病子宮腺肌病) medial, severe pain, uterus slightly enlarged treatment principles of treatment: treatment should be individualized according to the age, severity of the condition and desire for childbearing. with mild sy

12、mptom: expectant therapy with childbearing desire: mild-condition: medication severe-condition: fertility preservation surgery no childbearing desire : surgical treatment: ovary preservation or radical surgery treatment expectant therapy follow-up symptoms management:nsaids(非甾體類抗炎藥)(非甾體類抗炎藥) treatme

13、nt medication objective: cause atrophic changes in the ectopic endometrium (使異位內(nèi)膜萎縮)(使異位內(nèi)膜萎縮) medication pseudopregnancy therapy oral contraceptives:a pill once daily for 6-12 m progestins: medroxyprogesterone (醋酸甲孕酮)(醋酸甲孕酮)30mg daily megestrol (甲地孕酮)(甲地孕酮) 40mg daily norethindrone (炔諾酮)(炔諾酮) 5mg da

14、ily side effects: intermittent breakthrough bleeding, nausea, breast tenderness, fluid retention, weight gain medication pseudomenopause therapy gnrh-a mechanism: medical hypophysectomy (藥物性垂體切除) / medical oophorectomy (藥物性卵巢切除) leuprorelin (亮丙瑞林,抑那通)(亮丙瑞林,抑那通)3.75mg goserelin (戈舍瑞林,諾雷德)(戈舍瑞林,諾雷德)3.

15、6mg tryptorelin (曲普瑞林,達(dá)菲林)(曲普瑞林,達(dá)菲林) 3.75mg m / h, 1 inj/q28d, start d1 medication gnrh-a side effects: (1) menopausal symptoms : hot flashes, dryness in vagina, loss of libido(性欲性欲) (2) osteoporosis medication pseudomenopause therapy danazol a derivative of 17-ethinyltestosterone (17-乙炔睪酮衍生物)乙炔睪酮衍生

16、物) mechanism: directly suppressing ovarian steroidogenesis (甾體激素生成) direct inhibiting the growth of endometrium 400-600 mg/d for 6 months medication danazol side effects: acne, deepening of the voice, oily skin, headache, hot flashes, loss of libido, weight gain medication others: gestrinone (孕三烯酮)

17、mifepristone(米非司酮) surgical treatment purposes: diagnosis and classification excise or destroy all endometriotic tissue remove all adhesions, restore pelvic anatomy enhance fecundity relieve pain surgical treatment laparoscopy + medicine golden standard of treatment surgical treatment modes of surgi

18、cal operation: (1) fertility preservation (2) ovarian function preservation (3) radical surgery (4) surgery for pain relief treatment combination of medication and surgery treatment for patients with infertility prevention prevent retrograde flow of menses contraception with medicine avoid iatrogenic (醫(yī)源性醫(yī)源性) implantation of the ectopic endometrium adenomyosis adenomyosis is defined by the presence of endometrial glands and stroma within the myometrium. it is associated with myometrial hypertrophy and proliferation. pathogenesis histological confirmati

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論